发明申请
US20090169557A1 Whole glucan particles in combination with antibiotics, vaccines and viral monoclonal antibodies
审中-公开
全葡聚糖颗粒与抗生素，疫苗和病毒单克隆抗体结合使用
- 专利标题： Whole glucan particles in combination with antibiotics, vaccines and viral monoclonal antibodies
- 专利标题（中）： 全葡聚糖颗粒与抗生素，疫苗和病毒单克隆抗体结合使用
-
申请号： US11579467申请日： 2005-05-10
-
公开(公告)号： US20090169557A1公开(公告)日： 2009-07-02
- 发明人: Gordon D. Ross , Trunetta Jo Dockter Ross , Steven J. Karel , Daniel K. Connors , Bill Kournikakis
- 申请人： Gordon D. Ross , Trunetta Jo Dockter Ross , Steven J. Karel , Daniel K. Connors , Bill Kournikakis
- 专利权人： Biopolymer Engineering, Inc. d/b/a Biothera
- 当前专利权人： Biopolymer Engineering, Inc. d/b/a Biothera
- 国际申请： PCT/US05/16229 WO 20050510
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61K31/716 ; A61K39/00 ; A61P31/12
摘要：
The present invention relates to compositions and methods of using whole glucan particles and agents. Whole glucan particles enhance the tumoricidal activity of the innate immune system by binding to the C3 complement protein receptor CR3. This binding enhances innate immune system cytotoxicity, as well as stimulating the release of activating cytokines and enhances the bodies response to the agent.
信息查询
